GluPredKit: Development and User Evaluation of a Standardization Software for Blood Glucose Prediction
GluPredKit: Development and User Evaluation of a Standardization Software for Blood Glucose Prediction
Blood glucose prediction is an important component of biomedical technology for managing diabetes with automated insulin delivery systems. Machine learning and deep learning algorithms hold the potential to advance this technology. However, the lack of standardized methodologies impedes direct comparisons of emerging algorithms. This study addresses this challenge by developing GluPredKit, a software platform designed to standardize the training, testing, and comparison of blood glucose prediction algorithms. GluPredKit features a modular, open-source architecture, complemented by a commandline interface, comprehensive documentation, and a video tutorial to enhance usability. To ensure the platform’s effectiveness and user-friendliness, we conducted preliminary testing and a user study. In this study, four participants interacted with GluPredKit and provided feedback through the System Usability Scale (SUS) and open-ended questions. The findings indicate that GluPredKit effectively addresses the standardization challenge and offers high usability, facilitating direct comparisons between different algorithms. Additionally, it serves an educational purpose by making advanced methodologies more accessible. Future directions include continuously enhancing the software based on user feedback. We also invite community contributions to further expand GluPredKit with state-of-the-art components and foster a collaborative effort in standardizing blood glucose prediction research, leading to more comparable studies
https://arxiv.org/pdf/2406.08915
M. K.Wolff, S. Royston, A. L. Fougner, H. G. Schaathun, M. Steinert and R. Volden, "GluPredKit: Development and User Evaluation of a Standardization Software for Blood Glucose Prediction", published in Norwegian ICT Conference for Research and Education (NIKT 2024), Bergen, Norway, November 2024.
